Another unique feature is that the TERT promoter is unmethylated in normal human cells, whereas methylated in malignant cells, and Lee et al. identified the 52 CpG-containing TERT hypermethylated oncological region (THOR) as a cancer-associated epigenetic mechanism of TERT upregulation [23–26]. Here, TERT is linked to cancer.